Protecting Biopharmaceutical Innovation Means Hope for New Treatments for Patients

The TPP offers an opportunity for governments to encourage patient access to medicines by ensuring that their regulatory and legal frameworks value innovation and the underlying intellectual property to develop new and improved medicines for patients.

Addressing the real barriers to access is the responsibility of many stakeholders, including governments, the private sector, and non-governmental organizations.

Protecting Biopharmaceutical Innovation Means Hope for New Treatments for Patients

TPP & Innovation.pdf